MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 103 filers reported holding MAXCYTE INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $272,170 | -15.7% | 87,234 | +24.0% | 0.00% | – |
| Q2 2023 | $322,995 | -25.0% | 70,369 | -19.1% | 0.00% | – |
| Q1 2023 | $430,536 | -83.9% | 86,977 | -82.3% | 0.00% | – |
| Q4 2022 | $2,676,777 | -43.4% | 490,252 | -32.6% | 0.00% | -100.0% |
| Q3 2022 | $4,730,000 | +2991.5% | 727,799 | +2148.7% | 0.00% | – |
| Q2 2022 | $153,000 | -67.2% | 32,366 | -51.4% | 0.00% | – |
| Q1 2022 | $466,000 | -5.1% | 66,612 | +38.4% | 0.00% | – |
| Q4 2021 | $491,000 | +1483.9% | 48,147 | +1761.8% | 0.00% | – |
| Q3 2021 | $31,000 | – | 2,586 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NORTH RUN CAPITAL, LP | 480,900 | $3,361,000 | 4.94% |
| Casdin Capital, LLC | 13,971,334 | $97,660,000 | 4.38% |
| Vitruvian Partners LLP | 4,385,670 | $30,656,000 | 3.25% |
| RIVER GLOBAL INVESTORS LLP | 2,100,000 | $14,849,000 | 1.95% |
| APIS CAPITAL ADVISORS, LLC | 180,000 | $1,258,000 | 1.52% |
| Pier Capital, LLC | 1,017,753 | $7,114,000 | 0.91% |
| First Light Asset Management, LLC | 1,321,406 | $9,237,000 | 0.82% |
| Montanaro Asset Management Ltd | 929,000 | $6,557,000 | 0.81% |
| Nicholas Investment Partners, LP | 776,963 | $5,431,000 | 0.39% |
| Bleichroeder LP | 250,000 | $1,764,000 | 0.31% |